In addition, the RTK I and MES tumour patients of our study cohort showed significantly different patients’ survival, and low SOX10 expression in MES-subtype glioblastoma of the TCGA cohort significantly correlated with adverse prognosis (Fig. 7i, j). This evidence concerns the gene SOX10 and glioblastoma.